【摘要】 随着药物洗脱支架(Drug Eluting Stent,DES)的出现,再狭窄的问题得到进一步的有效控制。然而,药物洗脱支架也存在较低的再狭窄率,由于应用药物洗脱支架治疗人数非常多,这一比率就不容忽视。本文将阐述DES支架内再狭窄发生的病理生理学机制、临床表现、形态学特征以及处理策略。更多还原

【Abstract】 With the emergence of drug-eluting stents(DES),restenosis have further effective controled.However,a low rate of in-stent restenosis(ISR) after DES still exists,and its prevalence is not negligible because the population treated with DES is large.We sought to provide a concise,comprehensive overview of the pathophysiologic mechanisms,clinical presentation,morphologic patterns,and management options of DES ISR.更多还原